BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7203274)

  • 1. [Chemical structure biliary excretion of iodine-containing contrast agents in hemoglobin-free perfused rat liver and in vivo (author's transl)].
    Azuma H; Oshino N
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(5):321-32. PubMed ID: 7203274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biliary transport of organic anions in the isolated hemoglobin-free perfused rat liver (author's transl)].
    Azuma H; Oshino N
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(5):307-19. PubMed ID: 7203273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the biliary excretion of the hepatotropic contrast media ioglycamate and iotroxinate in pigs and men (author's transl)].
    Klapdor R; Aban Y; Sepehr H; Scherer K
    Rontgenblatter; 1978 Feb; 31(2):114-9. PubMed ID: 635378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics and plasma albumen binding of iotroxic acid (Biliscopin), iodoxic acid (Endomirabil) and ioglycamine (Biligram) (author's transl)].
    Taenzer V; Speck U; Wolf R
    Rofo; 1977 Mar; 126(3):262-7. PubMed ID: 139346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of drug-drug interactions: biliary excretion of iodoxamic acid and iopanoic acid in rhesus monkeys.
    Lin SK; Moss AA; Riegelman S
    J Pharm Sci; 1979 Nov; 68(11):1430-3. PubMed ID: 117095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced cholestatic potency of taurolithocholate during backward perfusion of the rat liver.
    Baumgartner U; Hardison WG; Miyai K
    Lab Invest; 1987 Jun; 56(6):576-82. PubMed ID: 3599905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and physiology of the biliary radiographic contrast materials.
    Berk RN; Loeb PM
    Semin Roentgenol; 1976 Jul; 11(3):147-56. PubMed ID: 133461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholangiographic excretion studies: a comparison of iodipamide and iodoxamate in the dog.
    Evill CA; Benness GT
    Invest Radiol; 1976 SEP-OCT; 11(5):459-63. PubMed ID: 989759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmaco-kinetic investigations of a new gall bladder contrast medium--iodoxaminic acid (author's transl)].
    Mähner B; Krüger R; Siehr U; Wilhelmi U
    Rofo; 1976 Dec; 125(6):556-9. PubMed ID: 137854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal radiology. Pharmacokinetics of iopanoate and iodoxamate in rhesus monkeys.
    Moss AA; Lin SK; Riegelman S
    Invest Radiol; 1980; 15(6 Suppl):S132-5. PubMed ID: 6894137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic uptake and biliary excretion of d-tubocurarine and trimethyltubocurarine in the rat in vivo and in isolated perfused rat livers.
    Meijer DK; Weitering JG; Vonk RJ
    J Pharmacol Exp Ther; 1976 Jul; 198(1):229-39. PubMed ID: 933009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Animal experiments on the distribution and excretion of an intravenously injected biliary contrast medium (Ioglycomate) (author's transl)].
    Hilweg D
    Rofo; 1976 Apr; 124(4):320-7. PubMed ID: 131756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiology of biliary excretion of roentgenographic contrast media (author's transl)].
    Fuchs WA
    Radiologe; 1977 Feb; 17(2):64-9. PubMed ID: 322197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary excretion of iodipamide and iodoxamate in normal and common bile duct-obstructed dogs.
    Burgener FA; Fischer HW; Denyon TD
    Invest Radiol; 1978; 13(3):255-63. PubMed ID: 581381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that interference with binding to hepatic cytosol binders can inhibit bile acid excretion in rats.
    Takikawa H; Sugiyama Y; Fernandez-Checa JC; Kuhlenkamp J; Ookhtens M; Kaplowitz N
    Hepatology; 1996 Jun; 23(6):1642-9. PubMed ID: 8675188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic modeling of hepatic transport from cells to whole body: application to napsagatran and fexofenadine.
    Poirier A; Funk C; Scherrmann JM; Lavé T
    Mol Pharm; 2009; 6(6):1716-33. PubMed ID: 19739673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between chemical structure and physicochemical properties of series of bulky organic cations and their hepatic uptake and biliary excretion rates.
    Proost JH; Roggeveld J; Wierda JM; Meijer DK
    J Pharmacol Exp Ther; 1997 Aug; 282(2):715-26. PubMed ID: 9262335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of ioglycamic acid, iodoxamic acid and iotroxic acid in man.
    Mützel W; Taenzer V; Wolf R
    Invest Radiol; 1976; 11(6):598-601. PubMed ID: 1036733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saturation kinetics and choleretic effects of iodoxamate and iodipamide.
    Berk RN; Loeb PM; Cobo-Frenkel A; Barnhart JL
    Radiology; 1976 Jun; 119(3):529-36. PubMed ID: 947095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Bromoisovalerylurea as model substrate for studies on pharmacokinetics of glutathione conjugation in the rat. II. Pharmacokinetics and stereoselectivity of metabolism and excretion in vivo and in the perfused liver.
    te Koppele JM; Dogterom P; Vermeulen NP; Meijer DK; van der Gen A; Mulder GJ
    J Pharmacol Exp Ther; 1986 Dec; 239(3):905-14. PubMed ID: 3795049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.